Graft function 5-7 years after renal transplantation in early childhood

E Qvist1, J Laine, K Rönnholm

  • 1Hospital for Children and Adolescents, Pediatric Nephrology and Transplantation, University of Helsinki, Finland. erik.qvist@helsinki.fi

Transplantation
|April 30, 1999
PubMed

Insights

Kidney transplants in young children show excellent long-term graft survival and function with triple immunosuppression. This study followed 49 pediatric kidney transplant recipients for up to 7 years.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Renal Physiology

Background:

  • Low recipient age is a risk factor for graft failure in kidney transplantation.
  • Limited prospective data exists on long-term graft function in young children post-renal transplant.

Purpose of the Study:

  • To prospectively evaluate long-term graft function and survival in pediatric kidney transplant recipients.
  • To assess the impact of donor type (living related vs. cadaveric) and recipient age at transplant on outcomes.

Main Methods:

  • Prospective follow-up of 49 kidney allograft recipients transplanted before age 5.
  • Assessment of glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and electrolyte/urate handling for up to 7 years.
  • Comparison of outcomes between living related donor (LRD) and cadaveric kidney (CAD) recipients, and between younger (<2 years) and older (>2 years) recipients.

Main Results:

  • Seven-year patient survival was 100% (LRD) and 96% (CAD); graft survival was 94% (LRD) and 79% (CAD).
  • Mean GFR remained stable, but was lower in children transplanted at <2 years compared to >2 years (54 vs. 75 ml/min/1.73 m2, P=0.02).
  • Hyperuricemia and subnormal concentrating capacity were common, with some patients showing abnormal potassium handling.

Conclusions:

  • Triple immunosuppression provides excellent long-term graft survival and good function in young kidney transplant recipients.
  • Even young cadaveric kidney recipients can achieve favorable outcomes with this immunosuppression regimen.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...